_PRO_SUR-01-min.png)
Description
- Glycerol and fatty acids can penetrate through the bacterial cell wall. Their specific amphiphilic properties allow them to break down bacterial cell membranes, release the cells and inhibit the growth of bacteria.
- Control of major pathogens through protein leaks and intracellular hydrolysis, has a bactericidal effect that helps maintain resistance to dangerous diseases caused by infection in shrimp (EMS, AHPND, WFS,... Does not affect beneficial microorganisms in the gut and improves growth.
- Counteracting Vibrio parahaemolyticus formation by preventing bacteria from multiplying helps to prevent and reduce the progression of AHPND/EMS.
- With emulsifying properties can increase the permeability of bacteria cell membranes and cause them to die.
- Inhibits the activation of Phospholipids, proliferation of most Gram-negative bacteria. Thereby inhibiting the pathogens of hepatopancreas and white feces in shrimp.
- Improved digestibility of proteins and other nutrients such as starches and fats.
- A low pH environment increases mineral solubility and increases the absorption of calcium, magnesium and especially phosphorus.
PRACTICAL APPLICATION OF PRO SUR
Evaluation of shrimp growth in 30 days
Test shrimp weight from 1 – 1,5 g, density: 50 shrimp/tank 150L.
Feeding 4 times / day.
Test dosage:
- Control (not used).
- PRO SUR (6 ml/kg feed).
- PRO SUR (8 ml/kg feed).
|
The treatment |
Weight (g) |
|
Control experiment |
1,9 |
|
Pro Sur * L (6ml/kg feed) |
3,16 |
|
Pro Sur * L (8ml/kg feed) |
3,33 |
Experimental assessment of survival after infection (AHPND/EMS)
- Evaluate survival 10 days before AHPND/EMS, 10 days after illness in good conditions.
- Experiments were performed on shrimp weighing 1,5 g; density 35 shrimp/tank 90 liters, feeding 6 - 8 times/day.
|
The treatment |
Survival rate (%) |
|
Positive control |
80,5 |
|
Negative control |
7,1 |
|
Pro Sur * L (3ml/kg of feed) |
24,1 |
|
Pro Sur * L (6ml/kg of feed) |
28,1 |
PRO SUR reduces the density of Vibrio in shrimp, thereby reducing the effects on hepatopancreas and intestinal diseases, especially white feces disease.
